Navigation Links
Tarsa Therapeutics Reports Positive Top-Line Results From Pivotal Phase III ORACAL Trial of its Oral Calcitonin in Treatment of Postmenopausal Osteoporosis
Date:3/24/2011

erm=tarsa">www.clinicaltrials.gov/ct2/results?term=tarsa.

Tarsa is developing its oral calcitonin program under a licensing agreement with Unigene Laboratories that provides Tarsa with exclusive development and worldwide commercialization rights to Unigene's oral calcitonin product, with the exception of China.

About Osteoporosis

Osteoporosis is a common disease characterized by the loss of bone mass (thinning of bones) that leads to an increase in bone fragility and heightened risk of fractures. The National Osteoporosis Foundation reports that in the US, approximately 10 million individuals already have osteoporosis and an additional 34 million have low bone mass (also known as osteopenia), placing them at increased risk of developing osteoporosis.  The International Osteoporosis Foundation reports that osteoporosis affects an estimated 75 million people in the US, Europe and Japan.  Risk factors include family history, age, postmenopausal status, low dietary calcium intake, sedentary lifestyle and use of certain medications. As life spans increase globally, the number of individuals at risk of osteoporosis will continue to rise. At age 50, approximately one in two women and one in four men can expect to have an osteoporosis-related fracture during the remainder of their lives, with the risk increasing with age.  Fractures resulting from osteoporosis can be painful and debilitating, compromising the quality of patients' lives and in the case of hip fractures, increasing the risk of institutionalization, disability and early mortality.  For more information visit:  www.niams.nih.gov/HealthInfo/Bone or www.nof.org.

About Tarsa Therapeutics

Tarsa Therapeutics is developing an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.  Calcitonin ha
'/>"/>

SOURCE Tarsa Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
11. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014 Quantum Materials Corp (OTCQB:QTMM) ... of photoactive quantum dots for use in ... numerous advantages for solar power generation, the high ... quantum dots with which to develop thin film ... commercial utilization and acceptance. The company is also ...
(Date:10/1/2014)... -- CVS Health is thanking its 26,000 pharmacists during October,s ... way health care is delivered to increase access, lower ... mail service pharmacies and specialty pharmacies nationwide.  ... CVS Health to reflect our broader health care commitment ... shape the future of health," said Larry Merlo ...
(Date:9/30/2014)... LONDON , Sept. 30, 2014 This report ... Million by the following Product Categories: Enteral Feeding Pumps, Nasogastric ... analytics for the US Canada, Japan , ... Latin America , and Rest of World. ... through 2018. Also, a six-year historic analysis is provided for ...
Breaking Medicine Technology:Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 2Quantum Materials Scaling Up Photoactive Quantum Dot Production for Solar Power Generation 3CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 2CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 3Global Enteral Feeding Devices Industry 2Global Enteral Feeding Devices Industry 3Global Enteral Feeding Devices Industry 4Global Enteral Feeding Devices Industry 5Global Enteral Feeding Devices Industry 6Global Enteral Feeding Devices Industry 7Global Enteral Feeding Devices Industry 8Global Enteral Feeding Devices Industry 9Global Enteral Feeding Devices Industry 10Global Enteral Feeding Devices Industry 11Global Enteral Feeding Devices Industry 12Global Enteral Feeding Devices Industry 13Global Enteral Feeding Devices Industry 14Global Enteral Feeding Devices Industry 15Global Enteral Feeding Devices Industry 16Global Enteral Feeding Devices Industry 17Global Enteral Feeding Devices Industry 18Global Enteral Feeding Devices Industry 19
... TEMPE, Ariz., Oct. 27 Intrinsic Bioprobes today ... Office has issued US Patent 7,816,095 covering novel ... patent is first of a series of patent ... biomarkers with clinical utility. "The biomarkers ...
... Boston Scientific Corporation (NYSE: BSX ) ... Asthmatx, Inc. of Sunnyvale, California.  The transaction follows ... the terms of the agreement, Boston Scientific purchased ... $193.5 million.  Additional payments of up to $250 ...
Cached Medicine Technology:Intrinsic Bioprobes Announces Issuance of US Patent for Novel Biomarkers and Assays for Myocardial Infarction 2Boston Scientific Completes Acquisition of Asthmatx 2Boston Scientific Completes Acquisition of Asthmatx 3
(Date:10/1/2014)... brain of a rat and a robot could revolutionise ... leading robotics researcher. , Dr Michael Milford from ... uses new computer algorithms to enable robots to navigate ... is a very Frankenstein type of project," Dr Milford ... together because we,re taking the eyes of a human ...
(Date:10/1/2014)... Patients with increased inflammation, including those receiving cytokines ... of depression. For example, a 6-month treatment course ... infection causes depression in approximately 30% of patients. ... as fish oil, have a long list of ... disease and reducing triglyceride levels. These nutritional compounds ...
(Date:10/1/2014)... suggests the adage that encourages people to keep their ... it comes to exercise. When walking, staying focused on ... it appear shorter and help people walk there faster, ... technique to walking while looking around the environment naturally, ... exercise. , "People are less interested in exercise if ...
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new blog post explaining how ... Senior citizens can purchase a joint life insurance policy ... joint policy is cheaper, but will only pay benefits ... insurance can be used to cover important funeral expenses. ... as the application process is simple and straightforward. ...
(Date:10/1/2014)... Chino Hills, CA (PRWEB) October 01, 2014 ... the internationally-franchised Fit Body Boot Camp fitness boot camps, ... selling personal training , with sold out business ... a stint as marketing consultant to a recent Spike ... looming, Keuilian says that now is the time for ...
Breaking Medicine News(10 mins):Health News:Robot researcher combines nature to nurture 'superhuman' navigation 2Health News:Omega-3 fatty acids may prevent some forms of depression 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 3Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3
... A clinical trial in Cambodia has found it possible ... very weak immune systems and newly diagnosed tuberculosis (TB) ... treatment, rather than waiting eight weeks, as has been ... Institute of Allergy and Infectious Diseases (NIAID), part of ...
... July 22 Adult circumcision has been proposed as a ... study by the University of Pittsburgh Graduate School of ... suggests it would have a very small effect on reducing ... thought to reduce the risk of HIV transmission by removing ...
... insulin resistance and the action of diabetes drugs such ... improved medications that are more selective and safer, say ... Institute. "Our findings strongly suggest that good and ... designing second-generation drugs that focus on the newly uncovered ...
... College Park, MD (July 20, 2010) -- Eighty years ago, ... of metabolism, but the idea went out of vogue. Now, ... cancer and other common diseases. Metabolism is a highly connected ... pathways. Such parallelism can mask how genes are linked ...
... Cancer surgery wreaks havoc on a body,s immune system and ... of those who undergo surgery for tumor removal experience a ... of the body. A new clinical approach being ... the key to making cancer operations more successful. Prof. Shamgar ...
... group of patients at one of the nation,s largest ... who have previously refused colorectal cancer screening, are willing ... but not willing to pay for the exam themselves ... in the August issue of the American Journal ...
Cached Medicine News:Health News:NIH-funded study finds early HAART during TB treatment boosts survival rate in co-infected people 2Health News:Scientists find unsuspected molecular link between obesity and insulin resistance 2Health News:Scientists find unsuspected molecular link between obesity and insulin resistance 3Health News:A new drug treatment to close the window on colon cancer 2Health News:Lack of insurance coverage remains obstacle to wider colorectal cancer screening with CT colonography 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: